Granite Point Capital Management’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-40,000	Closed	-$745K	–	136
2021 Q3	$745K	Sell	40,000 -10,000	-20%	-$186K	0.06%	84
2021 Q2	$1.06M	Buy	+50,000	New	+$1.06M	0.04%	90